To include your compound in the COVID-19 Resource Center, submit it here.

Combined inhibition of CDK12 and CDK13 for TNBC

DISEASE CATEGORY: Cancer

INDICATION: Breast cancer

A Moffitt Cancer Center and Research Institute team showed that dual inhibition of CDK12 and

Read the full 191 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE